Table 1.
Prevalence of Parkinsonism by age and location for both sexes.
| Age groups years (n) | 65–69Rate (CI) | 70–74Rate (CI) | 75–79Rate (CI) | 80 +Rate (CI) | TotalRate (CI) |
|---|---|---|---|---|---|
| Cuba | N = 757 | N = 789 | N = 627 | N = 730 | N = 2903 |
| Female (n = 1 880) | 2.3 (1.3-4.1) | 4.1 (2.66.2) | 7.0 (4.9–10.0) | 12.1(9.5–15.3) | 6.4 (5.4−7.6) |
| Male (n = 1023) | 2.1 (1.0-4.8) | 3.1 (1.6–5.8) | 5.2 (3.0–9.0) | 15.9 (11.7 −21.3) | 6.2 (4.8–7.8) |
| Total (n = 2903) | 2.3 (1.4–3.6) | 3.7 (2.6–5.3) | 6.4 (4.7–8.6) | 13.3 (11.0–15.9) | 6.3 (5.5-7.3) |
| Dominican Republic | n = 516 | n = 494 | n = 368 | n = 457 | n = 1835 |
| Female (n = 1192) | 2.4 (1.2–4.7) | 9.1 (6.3–12.9) | 10.0 (6.8–14.4) | 18.1 (14.1–22.9) | 9.7 (8.1–11.5) |
| Male (n = 643) | 6.5 (3.4–11.2) | 10.1(6.5–15.4) | 14.2 (9.0–21.8) | 24.0 (17.9–31.4) | 13.2 (10.8–16.1) |
| Total (n = 1835) | 3.9 (2.5–5.9) | 9.5 (7.2–12.4) | 11.4 (8.5–15.1) | 20.1 (1.7–24.1) | 10.9 (9.6–12.4) |
| Puerto Rico | n = 339 | n = 376 | n = 402 | n = 487 | n = 1604 |
| Female (n = 1083) | 2.0 (0.8–4.6) | 1.6 (0.6–4.2) | 8.4 (5.7–12.4) | 16.0 (12.4–20.6) | 7.5 (6.1–9.2) |
| Male (n = 521) | 2.4 (0.6–9.2) | 6.3 (3.2–12.1) | 7.6 (4.1–13.6) | 20.4 (15.1–27.1) | 10.8 (8.4–13.8) |
| Total (n = 1604) | 2.1 (1.0–4.3) | 3.2 (1.8–5.5) | 8.2 (5.9–11.3) | 17.6 (14.5–21.3) | 8.6 (7.3–10.1) |
| Peru (urban) | n = 368 | n = 351 | n = 296 | n = 343 | n = 1358 |
| Female (n = 874) | 4.6 (2.6–7.9) | 5.9 (3.4–9.9) | 6.3 (3.6–10.8) | 11.2 (7.5–16.3) | 6.9 (5.4–8.7) |
| Male (n = 485) | 3.7 (1.4–9.5) | 3.0 (1.1–7.8) | 14.0 (8.6–22.0) | 18.1 (12.5–25.4) | 9.9 (7.5–12.9) |
| Total (n = 1359) | 4.3 (2.7–7.0) | 4.8 (3.0–7.) | 9.1 (6.3–13.0) | 14.0 (10.7–18.1) | 7.9 (6.6–9.5) |
| Peru (rural) | n = 179 | n = 140 | n = 99 | n = 128 | n = 546 |
| Female (n = 291) | 5.0 (2.1–11.5) | 7.3 (3.3–15.4) | 3.9 (1.0–14.5) | 17.3 (9.5–29.3) | 7.9 (5.311.6) |
| Male (n = 255) | 6.3 (2.6–14.4) | 5.2 (1.6–15.0) | 4.1 (1.0–15.4) | 4.2 (1.3–12.5) | 5.1(3.0–8.6) |
| Total (n = 546) | 5.6 (3.0–10.1) | 6.4 (3.4–11.9) | 4.0 (1.5–10.3) | 10.2 (6.0–16.6) | 6.6 (4.7–9.0) |
| Venezuela | n = 610 | n = 335 | n = 249 | n = 206 | n = 1400 |
| Female (n = 893) | 1.0 (0.4–2.7) | 4.2 (2.2–8.0) | 9.9 (6.0–15.7) | 16.6 (11.4–23.6) | 5.8 (4.4–7.6) |
| Male (n = 507) | 4.0 (2.1–7.5) | 8.8 (4.9–15.3) | 7.3 (3.5–14.7) | 16.5 (8.8–27.5) | 7.3 (5.3–9.9) |
| Total (n = 1400) | 2.1 (1.2–3.6) | 6.0 (3.9–9.1) | 8.9 (5.9–13.1) | 16.5 (12.0–22.2) | 6.3 (5.2–7.7) |
| Mexico (urban) | n = 243 | n = 326 | n = 202 | n = 211 | n = 982 |
| Female (n = 648) | 1.6 (0.5–4.9) | 10.1 (6.6 −15.0) | 13.8 (8.7–21.2) | 26.3 (19.5–34.4) | 11.7 (9.4–14.4) |
| Male (n = 334) | 3.3 (0.8–12.5) | 2.5 (0.8 - 7.6) | 9.0 (4.3–17.7) | 17.9 (10.8–28.1) | 7.7 (5.3–11.2) |
| Total (n = 982) | 2.1 (0.8–4.9) | 7.4 (5.0 −10.8) | 11.9 (8.1–17.2) | 23.2 (18.0–29.4) | 10.3 (8.6–12.5) |
| México (rural) | n = 299 | n = 251 | n = 217 | n = 217 | n = 984 |
| Female (n = 590) | 2.0 (0.7–5.3) | 2.7 (1.0–7.0) | 9.1 (5.2–15.3) | 15.9 (10.2–23.9) | 6.4 (4.7–8.7) |
| Male (n = 394) | 1.9 (0.5–7.5) | 7.7 (3.9–14.8) | 8.2 (3.9–16.3) | 20.2 (13.5–29.1) | 9.6 (7.1–13.0) |
| Total (n = 984) | 2.0 (0.9–4.4) | 4.8 (2.7–8.2) | 8.8 (5.6–13.3) | 18.0 (13.4–23.7) | 7.7 (6.2–9.5) |
| All centres combined | n = 3311 | n = 3062 | N = 2460 | n = 2780 | n = 11,613 |
| Female (n = 7451) | 2.4 (1.8–3.1) | 5.5 (4.5–6.6) | 8.5 (7.3–10.1) | 15.6 (13.9–17.3) | 7.6 (7.0–8.2) |
| Male (n = 4162) | 3.8 (2.8–5.1) | 5.7 (4.5–7.2) | 8.6 (7.0–10.7) | 18.1 (15.8–20.6) | 8.8 (8.0–9.7) |
| Total (n = 11,613) | 2.8 (2.3–3.4) | 5.5 (4.8–6.4) | 8.6 (7.5–9.8) | 16.5 (15.1–17.9) | 8.0 (7.6–8.5) |
The overall gender-specific prevalence rates are age adjusted to the whole sample as standard population. Numbers in parentheses indicates 95% Confidence Interval. CI=confidence interval.